Accueil>>ACTH (1-17) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)

ACTH (1-17) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)

Catalog No.GC90299

Un fragment peptidique de l'ACTH

Products are for research use only. Not for human use. We do not sell to patients.

ACTH (1-17) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt) Chemical Structure

Taille Prix Stock Qté
1 mg
102,00 $US
En stock
5 mg
482,00 $US
En stock
10 mg
812,00 $US
En stock
25 mg
1 644,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

ACTH (1-17) is a peptide fragment of adrenocorticotropic hormone , a peptide hormone found in the brain that is involved in the biological stress response.1 It binds to melanocortin receptors (MCRs; Kis = 0.23, 14, 419, and 4,240 nM for MC1R, MC3R, MC4R, and MC5R, respectively).2 It is an agonist at MC1R, increasing adenylate cyclase activity with an EC50 value of 3.02 nM in HEK293 cells expressing MC1R.3 ACTH (1-17) (160 µg/kg, i.v.) increases mean arterial blood pressure (MAP) following bleeding-induced potension in a rat model of hemorrhagic shock 15-30 minutes after administration.4 It induces melanogenesis in a biphasic manner (EC50s = 0.0001 and 0.08 nM) and differentiation of melanocytes when used at concentrations ranging from 0.01 to 1,000 nM.3,5

Avis

Review for ACTH (1-17) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for ACTH (1-17) (human, mouse, rat, porcine, bovine, ovine) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.